Columbia China to Build New Hospital in Jiaxing
|
By HospiMedica International staff writers Posted on 12 Sep 2017 |

Image: An artist’s rendition of the new Columbia Jiaxing Hospital (Photo courtesy of Columbia China).
Columbia China (Shanghai, China) has begun construction of a Columbia Jiaxing Hospital in Zhejiang province. The multi-specialty hospital is part of a joint venture between Columbia Pacific Management (Seattle, WA, USA), and investment company Temasek (Singapore).
The hospital, which is expected to open in 2019, is located in the Jiaxing Economic and Technological Development Zone. Once completed, it will have a construction floor area of 120,000m2 with 500 beds; 10 operating theatres; six labor, delivery, recovery and postpartum (LDRP) rooms; and advanced diagnostic equipment. The hospital, which is being constructed at a cost of USD150 million, will serve a population of 4.5 million people who demand quality healthcare services. Patients will be able to use their public and commercial medical insurance.
“Columbia China broke ground on the new hospital today just eight months after acquiring the land; the speed is unprecedented and unheard of in China for a foreign hospital investment,” said Bee Lan Tan, President and CEO of Columbia China. “This would not have been possible without the commitment and efficiency of the Jiaxing government. Columbia China remains dedicated to bringing more international talent and resources to Jiaxing, so that the needs of the local population can be well served.”
“Columbia China strives to deliver the highest level of healthcare quality and service by putting patients at the center of everything we do,” said Nate McLemore, managing director of Columbia Pacific Management. “We are excited to open a hospital in Jiaxing, and are extremely committed to delivering world-class care across China with Columbia China hospitals and Cascade (Kaijian) senior living.”
Columbia Pacific Management has been operating in Asia for 20 years, opening its first hospital in Malaysia in 1996; the network now includes 27 hospitals and two clinics. In 2011 the firm became the first foreign-owned company to receive permission from the Chinese government to build senior care facilities and operates three such facilities, one in Beijing and two in Shanghai. Columbia Pacific also owns a 220-bed orthopedic hospital and two multi-specialty clinics in Shanghai, and is developing two other hospitals in Wuxi and Changzhou.
Related Links:
Columbia China
Columbia Pacific Management
Temasek
The hospital, which is expected to open in 2019, is located in the Jiaxing Economic and Technological Development Zone. Once completed, it will have a construction floor area of 120,000m2 with 500 beds; 10 operating theatres; six labor, delivery, recovery and postpartum (LDRP) rooms; and advanced diagnostic equipment. The hospital, which is being constructed at a cost of USD150 million, will serve a population of 4.5 million people who demand quality healthcare services. Patients will be able to use their public and commercial medical insurance.
“Columbia China broke ground on the new hospital today just eight months after acquiring the land; the speed is unprecedented and unheard of in China for a foreign hospital investment,” said Bee Lan Tan, President and CEO of Columbia China. “This would not have been possible without the commitment and efficiency of the Jiaxing government. Columbia China remains dedicated to bringing more international talent and resources to Jiaxing, so that the needs of the local population can be well served.”
“Columbia China strives to deliver the highest level of healthcare quality and service by putting patients at the center of everything we do,” said Nate McLemore, managing director of Columbia Pacific Management. “We are excited to open a hospital in Jiaxing, and are extremely committed to delivering world-class care across China with Columbia China hospitals and Cascade (Kaijian) senior living.”
Columbia Pacific Management has been operating in Asia for 20 years, opening its first hospital in Malaysia in 1996; the network now includes 27 hospitals and two clinics. In 2011 the firm became the first foreign-owned company to receive permission from the Chinese government to build senior care facilities and operates three such facilities, one in Beijing and two in Shanghai. Columbia Pacific also owns a 220-bed orthopedic hospital and two multi-specialty clinics in Shanghai, and is developing two other hospitals in Wuxi and Changzhou.
Related Links:
Columbia China
Columbia Pacific Management
Temasek
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
- USC Virtual Care Clinic to Employ Avatar Doctors
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







